Request a Premium Quote Breaking News Personalis, Tempus Partner to Commercialize Blood-Based Minimal Residual Disease Test Carisma Therapeutics to Start Phase I Trial of CAR Monocyte in HER2-Positive Cancers Candel Therapeutics Lays off Half its Workforce, Refocuses on Most Advanced Oncology Programs Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test Autolus Seeks FDA Approval for CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia Vertex Nets European Label Expansion for Kaftrio Combo in Younger Cystic Fibrosis Patients
